Concepedia

Publication | Open Access

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

DOIFull Paper Access

906

Citations

22

References

2007

Year

Robert A. Kyle, Ellen D. Remstein, Terry M. Therneau, Angela Dispenzieri, Paul J. Kurtin, Janice M. Hodnefield, Dirk R. Larson, Matthew F. Plevak, Diane F. Jelinek, Rafaël Fonseca,
New England Journal of Medicine

Abstract

The risk of progression from smoldering multiple myeloma to symptomatic disease is related to the proportion of bone marrow plasma cells and the serum monoclonal protein level at diagnosis.

References

YearCitations

Page 1